241 related articles for article (PubMed ID: 6883818)
1. Serum and dialyzate concentrations of intraperitoneal cephalothin in patients undergoing continuous ambulatory peritoneal dialysis.
Münch R; Steurer J; Lüthy R; Siegenthaler W; Kuhlmann U
Clin Nephrol; 1983 Jul; 20(1):40-3. PubMed ID: 6883818
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
Mounier M; Benevent D; Denis F
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intravenous and intraperitoneal fosfomycin in continuous ambulatory peritoneal dialysis.
Bouchet JL; Albin H; Quentin C; de Barbeyrac B; Vinçon G; Martin-Dupont P; Potaux L; Aparicio M
Clin Nephrol; 1988 Jan; 29(1):35-40. PubMed ID: 3383462
[TBL] [Abstract][Full Text] [Related]
4. Adequacy and nutrition in the absence of residual renal function in peritoneal dialysis.
Canale R; Barone RJ; Gimenez NS; Santopietro M; Ramirez L; Palliotti A; Romero P; Amado D
Adv Perit Dial; 2001; 17():230-4. PubMed ID: 11510282
[TBL] [Abstract][Full Text] [Related]
5. [Peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Evaluation of cephalothin/cephalexin monotherapy as initial treatment].
Hornstrup MK; Nielsen TG; Gahrn-Hansen B; Pedersen FB; Klausen M
Ugeskr Laeger; 1993 Nov; 155(45):3650-4. PubMed ID: 8256355
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
7. Evaluating peritoneal fluid transport in continuous peritoneal dialysis patients: a practical approach.
Zhe XW; Tian XK; Shan YS; Cheng L; Wang T
Nephron Clin Pract; 2007; 107(4):c123-7. PubMed ID: 17957122
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of cefdinir and its transfer to dialysate in patients with chronic renal failure undergoing continuous ambulatory peritoneal dialysis.
Tomino Y; Fukui M; Hamada C; Inoue S; Osada S
Arzneimittelforschung; 1998 Aug; 48(8):862-7. PubMed ID: 9748717
[TBL] [Abstract][Full Text] [Related]
9. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
10. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal pharmacokinetics of gentamicin in man.
de Paepe M; Lameire N; Belpaire F; Bogaert M
Clin Nephrol; 1983 Mar; 19(3):107-9. PubMed ID: 6839558
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intravenous and intraperitoneal cefuroxime in patients undergoing peritoneal dialysis.
Local FK; Munro AJ; Kerr DN; Sussman M
Clin Nephrol; 1981 Jul; 16(1):40-3. PubMed ID: 7273495
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics of piperacillin during continuous ambulatory peritoneal dialysis].
Ryckelynck JP; Debruyne D; Hurault De Ligny B; Moulin M
Pathol Biol (Paris); 1988 May; 36(5):507-10. PubMed ID: 3043348
[TBL] [Abstract][Full Text] [Related]
14. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
15. [Extended assessment of peritoneal transport kinetics of substances and water as an important element of integrated dialysis care].
Baczyński D; Antosiewicz S; Waniewski J; Marciniak M; Wańkowicz Z
Pol Merkur Lekarski; 2004 Aug; 17(98):110-3. PubMed ID: 15603317
[TBL] [Abstract][Full Text] [Related]
16. [Effects of nitroprusside and vibration on peritoneal transport of solutes in continuous ambulatory peritoneal dialysis patients].
Tan XY; Liu FY; Duan SB
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):357-60. PubMed ID: 12206001
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis.
Pancorbo S; Comty C
Nephron; 1982; 31(1):37-9. PubMed ID: 7110474
[TBL] [Abstract][Full Text] [Related]
18. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
Passadakis PS; Thodis ED; Panagoutsos SA; Selisiou CA; Pitta EM; Vargemezis VA
Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251
[TBL] [Abstract][Full Text] [Related]
19. Bidirectional peritoneal transport of albumin in continuous ambulatory peritoneal dialysis.
Joffe P; Henriksen JH
Nephrol Dial Transplant; 1995; 10(9):1725-32. PubMed ID: 8559496
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of various pharmacologic and conventional methods of increasing the effectiveness of peritoneal dialysis. IV. A large intraperitoneal dose of furosemide in the modeling of continuous peritoneal dialysis].
Grzegorzewska A
Przegl Lek; 1988; 45(11):770-5. PubMed ID: 3244842
[No Abstract] [Full Text] [Related]
[Next] [New Search]
